References
- AHFS, American Hospital Formulary Service (2002). Gerald, K. (Ed.). Drug Information. BethesdaMD, USA: American Society of Health-system Pharmacists, 2395–2396.
- Archontaki, H. A., Vertzoni, M. V., & Athanassiou-Malaki, M. H. (2002). Study of the inclusion complexes of bromazepam with β- and β-hydroxypropyl-cyclodextrins.Journal of Pharmaceutical and Biomedical Analysis, 28, 761–769., [PUBMED], [INFOTRIEVE], [CSA]
- Brazeau, G. A., & Fung, H.-L. (1989). Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro–in vivo correlation and predictability with mixed solvent systems.Pharmaceutical Research, 6, 766–771., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brazeau, G. A., & Fung, H.-L. (1990). Effect of organic co-solvent-induced skeletal muscle damage on the bioavailability of intramuscular [14C]diazepam.Journal of Pharmaceutical Sciences, 79, 773–777., [PUBMED], [INFOTRIEVE]
- Carpenter, J. P., Gomez, E. A., & Levin, J. L. (1981). Administration of lorazepam injection through intravenous tubing.American Journal of Hospital Pharmacy, 38, 1514–1516., [PUBMED], [INFOTRIEVE]
- DAB. (1999). Deutsches Arzneibuch, Kommentar zur Europaïschen Pharmacopea, Arzneibuch- Kommentar Wissenschaftliche Erläuterungen zum Arzneibuch. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH, 1121. , (Seite 1–7).
- DeLuca, P. P., & Boylan, J. C. (1992). Formulation of small volume parenterals. In: Avis, K., Lieberman, H., Lachman, L. (Eds.). Pharmaceutical Dosage Forms: Parenteral Medications. New York: Marcel Dekker, 173–248.
- (2002). European Pharmacopoeia. 4th ed. StrasbourgFrance: Council of Europe.
- Higuchi, T.,& Connors, K. A. (1965). Phase-solubility techniques.Advances in Analytical Chemistry and Instrumentation, 4, 117–212.
- Hoey, L. L., Guay, D.R.P., & Vance-Bryan, K. (1994). Storage of lorazepam in polyvinyl chloride bags.American Journal of Hospital Pharmacy, 51, 1825–1826., [PUBMED], [INFOTRIEVE], [CSA]
- Holvoet, C., Plaizier-Vercammen, J., Vander Heyden, Y., Gabriëls, M., & Camu, F. (2003). Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.International Journal of Pharmaceutics, 265, 13–26., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- http://www.cyclodex.com/indexa.html ( accessed May 2004).
- Irie, T., & Uekama, K. (1997). Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation.Journal of Pharmaceutical Sciences, 86, 147–162., [PUBMED], [INFOTRIEVE], [CROSSREF]
- KNMP, Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (Royal Dutch Society for Advancement of Pharmacy). (1999). 's GravenhageThe Netherlands: Informatorium Medicamentorum, 760–761.
- Li, P., Vishnuvajjala, R., Tabibi, S. E., & Yalkowsky, S. H. (1998). Evaluation of in vitro precipitation methods.Journal of Pharmaceutical Sciences, 87, 196–199., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Loftsson, T., & Brewster, M. E. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.Journal of Pharmaceutical Sciences, 85, 1017–1025., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Loftsson, T., & Brewster, M. (1997). Cyclodextrins as pharmaceutical excipients.Pharmaceutical Technology Europe, 9, 26–34.
- Ma, D. Q., Rajewski, R. A., Vander Velde, D., & Stella, V. J. (2000). Comparative effects of (SBE)7m-β-CD and HP-β-CD on the stability of two anti-neoplastic agents, melphalan and carmustine.Journal of Pharmaceutical Sciences, 89, 275–287., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Martens, H. J., De Goede, P. N., & Van Loenen, A. C. (1990). Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers.American Journal of Hospital Pharmacy, 47, 369–373., [PUBMED], [INFOTRIEVE]
- Martindale. (1999). Parfitt, K., Sweetman, S. C., Blake, P. S., Parsons, A. V. (Eds.). The Complete Drug Reference (32nd ed.). LondonUK: Pharmaceutical Press, 675–677.
- Mc Guire, T. M., Warren, A. N., & Fox, J. L. (1993). Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.American Journal of Hospital Pharmacy, 50, 1410–1414.
- Medina, J., Salvado, A., & del Pozo, A. (2001). Use of ultrasound to prepare lipid emulsions of lorazepam for intravenous injection.International Journal of Pharmaceutics, 216, 1–8., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- The Merck-Index. (1996). Budavari, S., O'Neil, M. J., Smith, A., Heckelman, P. E., Kinneary, J. F. (Eds.). An Encyclopedia of Chemicals, Drugs, and Biologicals (12th ed.). New Jersey: Merck Research Laboratories, 953.
- Narisawa, S., & Stella, V. J. (1998). Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-β-CD.Journal of Pharmaceutical Sciences, 87, 926–930., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Newton, D. W., Narducci, W. A., Leet, W. A., & Ueda, C. T. (1983). Lorazepam solubility in and sorption from intravenous admixture solutions.American Journal of Hospital Pharmacy, 40, 424–427., [PUBMED], [INFOTRIEVE]
- Rajewski, R. A., & Stella, V. J. (1996). Pharmaceutical applications of cyclodextrins. 2. In vivo delivery.Journal of Pharmaceutical Sciences, 85, 1142–1169., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Roquette, F. (2002). Kleptose®, Betacyclodextrins and Hydroxypropylbetacyclodextrins, Brochure. LestremFrance: Roquette Frères.
- Trapani, G., Latrofa, A., Franco, M., Pantaleo, M. R., Sanna, E., Massa, F., Tuveri, F., & Liso, G. (2000). Complexation of zolpidem with 2-hydroxypropyl-β-, methyl-β-, and hydroxypropyl-γ-cyclodextrin: effect on aqueous solubility, dissolution rate and ataxic activity in rat.Journal of Pharmaceutical Sciences, 89, 1443–1451., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Trissel, L. A., & Pearson, S. D. (1994). Storage of lorazepam in three injectable solutions in polyvinyl chloride and polyolefin bags.American Journal of Hospital Pharmacy, 51, 368–372., [PUBMED], [INFOTRIEVE]
- Yamamoto, M., Yoshida, A., Hirayama, F., & Uekama, K. (1989). Some physicochemical properties of branched β-cyclodextrins and their inclusion characteristics.International Journal of Pharmaceutics, 49, 163–171., [CROSSREF]